14 December 2017
News and Views
Links and Services
This week's New England Journal of Medicine assessed the efficacy and safety of TAS-102 in a global population.
Early clinical trials conducted primarily in Japan have shown that TAS-102, an oral agent that co
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors